Degenerative muscle fiber accelerates adipogenesis of intramuscular cells via RhoA signaling pathway.
In some pathological conditions such as Duchenne muscular dystrophy, it has been known that a fatty infiltration in skeletal muscle is often observed and that is also one of primary factors to induce marked decline of muscular strength. However, the mechanism of fatty infiltration, cellular origin of accumulated adipocytes and its significance are not fully understood. The fact that persistent degenerative muscle fibers are present on dystrophic muscle leads us to hypothesize that muscle fiber condition affects fatty infiltration in skeletal muscle. We employed a single fiber culture system to determine whether fiber condition affects an appearance of adipocytes on the fibers. Artificially hyper-contracted muscle fibers (HCF), generated from isolated intact fibers (IF) of rat extensor digitrum longus muscle, were maintained as non-adherent cultures for 5-7 days. Interestingly, there appeared to be considerable numbers of mature adipocytes on HCF, whereas no adipocytes were seen on IF, indicating that cells on HCF spontaneously differentiated into mature adipocytes. Activation of RhoA signaling by the addition of thrombin decreased the number of adipocytes on HCF in a dose-dependent manner, whereas the number of MyoD-positive myoblasts increased. In contrast, Y-27632, a specific inhibitor of Rho kinases (ROCK), induced adipogenic differentiation of cells derived from IF. In addition, administration of Y-27632 into mouse regenerating muscle resulted in fat accumulation in the muscle. Taken together, the present studies clearly demonstrated that muscle fiber condition affects fat accumulation in skeletal muscle and that is possibly mediated by the RhoA signaling pathway.
Hosoyama
Tohru
T
Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Ishiguro
Naomi
N
Yamanouchi
Keitaro
K
Nishihara
Masugi
M
D017667:Adipocytes / Q000166:cytology / Q000473:pathology; D050156:Adipogenesis / Q000187:drug effects / Q000502:physiology*; D000577:Amides / Q000494:pharmacology; D000818:Animals; D019070:Cell Lineage; D002478:Cells, Cultured; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018485:Muscle Fibers, Skeletal / Q000166:cytology / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D020388:Muscular Dystrophy, Duchenne; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D015398:Signal Transduction; D013917:Thrombin / Q000494:pharmacology; D020742:rhoA GTP-Binding Protein / Q000187:drug effects / Q000378:metabolism*
D000577:Amides; D009125:Muscle Relaxants, Central; D011725:Pyridines; C108830:Y 27632; D013917:Thrombin; D020742:rhoA GTP-Binding Protein